Medtronic plc (MDT) operating KPIs
MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026Score 19/303% below fair value
$96.54−0.57 (-0.59%)
Close on Oct 30, 2026Market cap $123.49BP/E 23.7Yield 2.94%
Medtronic cardiovascular — Segment R&D Expense ($M) ($M)
Medtronic Form 10-K/10-Q Segment Footnote XBRL (ASU 2023-07)
Latest, Q1 FY27
303
Period ended Jul 31, 2026
Change on a year earlier
+8.2%
280 in Q1 FY26
History
9 quarters
Since Q1 FY25
Sources
5
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cardiovascular — Segment R&D Expense ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q1 FY27 | Jul 31, 2026 | 303 | +8.2% | Medtronic Form 10-Q — FY2027Q1 (filed 2026-09-03) ↗ |
| Q4 FY26 | Apr 30, 2026 | 273 | +5.4% | Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗ |
| Q3 FY26 | Jan 31, 2026 | 284 | +14.5% | Medtronic Form 10-Q — FY2026Q3 (filed 2026-02-24) ↗ |
| Q2 FY26 | Oct 31, 2025 | 299 | +16.8% | Medtronic Form 10-Q — FY2026Q2 (filed 2025-11-25) ↗ |
| Q1 FY26 | Jul 31, 2025 | 280 | +8.9% | Medtronic Form 10-Q — FY2027Q1 (filed 2026-09-03) ↗ |
| Q4 FY25 | Apr 30, 2025 | 259 | – | Medtronic Form 10-K — FY2026 (filed 2026-06-18) ↗ |
| Q3 FY25 | Jan 31, 2025 | 248 | – | Medtronic Form 10-Q — FY2026Q3 (filed 2026-02-24) ↗ |
| Q2 FY25 | Oct 31, 2024 | 256 | – | Medtronic Form 10-Q — FY2026Q2 (filed 2025-11-25) ↗ |
| Q1 FY25 | Jul 31, 2024 | 257 | – | Medtronic Form 10-Q — FY2026Q1 (filed 2025-08-26) ↗ |
Breakdown
What makes up cardiovascular — segment r&d expense ($m)
Cite this data
StockData. (2026). Medtronic Cardiovascular — Segment R&D Expense ($M) ($M), quarterly Q1 FY25–Q1 FY27 [Data set]. Compiled from Medtronic SEC filings and investor materials. https://stockdatahq.com/stocks/mdt/kpis/seg-rd-cv
See every metric in the Medtronic KPI table. Data updated Oct 31, 2026.